Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CytoLogix v. Ventana

This article was originally published in The Gray Sheet

Executive Summary

Royalties of about $7 mil. payable to CytoLogix suggested by Ventana following Boston federal court jury's finding of patent infringement, although the firm "cannot reasonably estimate the final level of damages at the present time," Ventana says Dec. 23. CytoLogix' '061 and '693 patents were found to be infringed by Ventana's BenchMark and Discovery slide staining systems with independent heating on a moving platform. Ventana plans to appeal, despite the jury's conclusion that infringement was not willful, and that the firm is not liable for trade secret misappropriation, as CytoLogix charged in 2002 (1"The Gray Sheet" April 29, 2002, p. 22). Ventana plans to accelerate introduction of a non-infringing, multi-model, next-generation BenchMark XT platform in Q1...
Advertisement

Related Content

CytoLogix v. Ventana
CytoLogix v. Ventana: Anti-Trust Allegations Build On Trade Secret Suit
CytoLogix v. Ventana: Anti-Trust Allegations Build On Trade Secret Suit
Advertisement
UsernamePublicRestriction

Register

MT019557

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel